| Ms April Leanne Calderon, LCSW | |
|
4141 State St, Santa Barbara, CA 93110-1814 | |
| (805) 681-7144 | |
| Not Available |
| Full Name | Ms April Leanne Calderon |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 5 Years |
| Location | 4141 State St, Santa Barbara, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174260459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LCSW107856 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Indian Health And Services Corporation | 3375527880 | 11 |
News Archive
Each year prostate tissue samples are taken from over a million men around the world - in most cases using 12 large biopsy needles - to check whether they have prostate cancer.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 9.263 million cases and taken more than 477,000 lives as of June 24, 2020 – just six months after the initial outbreak in Wuhan, China, was reported. The illness, called COVID-19 disease, caused by SARS-CoV-2 is a severe pneumonic illness, caused by the entry of the virus into the type II alveolar cells.
A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA plus prednisone compared to patients treated with prednisone plus placebo.
A new discovery about selective serotonin reuptake inhibitors (SSRIs) suggests that these drugs, which are used to treat mental health disorders like depression and anxiety, have multiple effects on our cells. In a research report published in the August 2010 issue of GENETICS, researchers used yeast cells to identify secondary drug targets or pathways affected by SSRIs. Such secondary pathways could help explain why different people taking the same drug may experience different effects, and could also lead to new types of drugs altogether.
› Verified 8 days ago
| Entity Name | American Indian Health & Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740222934 PECOS PAC ID: 3375527880 Enrollment ID: O20040614001054 |
News Archive
Each year prostate tissue samples are taken from over a million men around the world - in most cases using 12 large biopsy needles - to check whether they have prostate cancer.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 9.263 million cases and taken more than 477,000 lives as of June 24, 2020 – just six months after the initial outbreak in Wuhan, China, was reported. The illness, called COVID-19 disease, caused by SARS-CoV-2 is a severe pneumonic illness, caused by the entry of the virus into the type II alveolar cells.
A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA plus prednisone compared to patients treated with prednisone plus placebo.
A new discovery about selective serotonin reuptake inhibitors (SSRIs) suggests that these drugs, which are used to treat mental health disorders like depression and anxiety, have multiple effects on our cells. In a research report published in the August 2010 issue of GENETICS, researchers used yeast cells to identify secondary drug targets or pathways affected by SSRIs. Such secondary pathways could help explain why different people taking the same drug may experience different effects, and could also lead to new types of drugs altogether.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms April Leanne Calderon, LCSW 4831 San Gordiano Ave Apt C, Santa Barbara, CA 93111-2213 Ph: (805) 570-2554 | Ms April Leanne Calderon, LCSW 4141 State St, Santa Barbara, CA 93110-1814 Ph: (805) 681-7144 |
News Archive
Each year prostate tissue samples are taken from over a million men around the world - in most cases using 12 large biopsy needles - to check whether they have prostate cancer.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 9.263 million cases and taken more than 477,000 lives as of June 24, 2020 – just six months after the initial outbreak in Wuhan, China, was reported. The illness, called COVID-19 disease, caused by SARS-CoV-2 is a severe pneumonic illness, caused by the entry of the virus into the type II alveolar cells.
A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA plus prednisone compared to patients treated with prednisone plus placebo.
A new discovery about selective serotonin reuptake inhibitors (SSRIs) suggests that these drugs, which are used to treat mental health disorders like depression and anxiety, have multiple effects on our cells. In a research report published in the August 2010 issue of GENETICS, researchers used yeast cells to identify secondary drug targets or pathways affected by SSRIs. Such secondary pathways could help explain why different people taking the same drug may experience different effects, and could also lead to new types of drugs altogether.
› Verified 8 days ago
Ms. Anita Fernandez-low, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1236 Chapala St, Santa Barbara, CA 93101 Phone: 805-455-8947 | |
Ms. Ericka K. Dixon, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1515 State Street, Suite 5, Santa Barbara, CA 93101 Phone: 805-403-7225 Fax: 805-965-1752 | |
Sebastian Lebeau, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 621 W Micheltorena St Ste B, Santa Barbara, CA 93101 Phone: 805-280-2832 | |
Ashleigh Dianna Erving, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 123 W Gutierrez St, Santa Barbara, CA 93101 Phone: 805-965-1001 | |
Mr. Agris Petersons, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 315 Camino Del Remedio, Santa Barbara, CA 93110 Phone: 805-681-5450 | |
Ms. Louise Ann Jansen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 315 Camino Del Remedio, Santa Barbara, CA 93110 Phone: 805-681-5450 Fax: 805-681-4747 | |
Stacey Sharpe, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 429 N San Antonio Rd, Santa Barbara, CA 93110 Phone: 805-884-1600 Fax: 805-739-8863 |